Focal and grid laser photocoagulation
Eye Care
≈ ¥800-2500
(≈ $110-350)
15 min
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer
Description
Estimated cost for Focal and grid laser photocoagulation at general public hospitals in China is about ¥560-2000, and at Grade 3A hospitals about ¥800-2500, varying by hospital tier and region.
Main Uses
Primary clinical uses include: 1) Treatment of diabetic macular edema (DME) — focal photocoagulation for discrete leaking microaneurysms and grid photocoagulation for diffuse edema; 2) Management of branch retinal vein occlusion (BRVO)-associated macular edema; 3) Stabilization of non-proliferative diabetic retinopathy (NPDR) to prevent progression; 4) Adjunctive therapy in select cases of retinal capillary hemangiomas or Coats’ disease; 5) Prevention of vision loss when anti-VEGF therapy is contraindicated, unavailable, or suboptimally responsive.
Normal Range
Retinal laser photocoagulation (focal/grid) is a therapeutic procedure, not a diagnostic test with quantitative laboratory values; therefore, there is no 'normal range' of numerical measurements. Clinical success is assessed qualitatively via ophthalmoscopic evaluation: absence of active leakage on fluorescein angiography (FA), resolution of macular edema on optical coherence tomography (OCT), stable or improved visual acuity (e.g., ≥20/40 Snellen), and absence of new hemorrhages or neovascularization.
Low Values - Possible Causes
Inadequate treatment response may manifest as persistent edema or leakage — causes include: 1) Subtherapeutic laser energy/duration, 2) Incomplete coverage of leaking microaneurysms (focal) or edematous areas (grid), 3) Progressive underlying disease (e.g., uncontrolled diabetes, hypertension), 4) Concomitant conditions impairing healing (e.g., renal failure, anemia), 5) Early post-procedure timing before biological effect fully manifests (typically 3–6 weeks).
High Values - Possible Causes
Excessive or inappropriate treatment effects — causes include: 1) Overly intense or confluent laser burns causing retinal scarring or atrophy, 2) Accidental foveal involvement leading to central vision loss, 3) Excessive treatment area triggering paradoxical inflammation or cystoid macular edema, 4) Pre-existing advanced retinopathy with poor tissue tolerance, 5) Laser-induced choroidal neovascularization (rare but reported in chronic cases).
Related Items
Dry Eye Syndrome Treatment
≈ ¥20-50
Phacoemulsification with intraocular lens implantation
≈ ¥8000-25000
Femtosecond laser-assisted cataract surgery (FLACS)
≈ ¥18000-35000
YAG laser capsulotomy
≈ ¥300-800
Intravitreal injection of ranibizumab
≈ ¥4500-6500
Intravitreal injection of conbercept
≈ ¥4800-6500